Skip to main content
. 2022 Jul 26;13:905634. doi: 10.3389/fimmu.2022.905634

Table 6.

Severity of adverse events among different groups.

AEs Group 1 (n=234) Group 2 (n=234) Group 3 (n=234) P value
Mild,n(%) Moderate,n(%) Severe,n(%) Mild,n(%) Moderate,n(%) Severe,n(%) Mild,n(%) Moderate,n(%) Severe,n(%)
Local AEs 22 (9.4) 39 (16.67) 10 (4.39) 21 (8.97) 5 (2.14) 3 (1.32) 16 (6.84) 25 (10.68) 9 (3.95) 0.006
pain 7 (2.99) 2 (0.85) 0 (0) 4 (1.71) 1 (0.43) 0 (0) 3 (1.28) 1 (0.43) 0 (0) 0.992
induration 5 (2.14) 8 (3.42) 2 (0.88) 2 (0.85) 0 (0) 1 (0.44) 6 (2.56) 5 (2.14) 1 (0.44) 0.721
redness 20 (8.55) 35 (14.96) 9 (3.95) 20 (8.55) 4 (1.71) 3 (1.32) 15 (6.41) 24 (10.26) 9 (3.95) 0.006
swelling 2 (0.85) 4 (1.71) 2 (0.88) 0 (0) 0 (0) 1 (0.44) 1 (0.43) 0 (0) 2 (0.88) 0.485
rash 1 (0.43) 1 (0.43) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0.43) 0 (0) 0 (0) 0.540
skin reactions 2 (0.85) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Systemic AEs 37 (15.81) 37 (15.81) 7 (3.07) 36 (15.38) 17 (7.26) 2 (0.88) 26 (11.11) 19 (8.12) 2 (0.88) 0.115
fever 34 (14.53) 25 (10.68) 2 (0.88) 20 (8.55) 9 (3.85) 1 (0.44) 19 (8.12) 10 (4.27) 2 (0.88) 0.720
irritability 10 (4.27) 0 (0) 0 (0) 10 (4.27) 0 (0) 0 (0) 10 (4.27) 0 (0) 0 (0) 1.000
vomit 5 (2.14) 0 (0) 1 (0.44) 7 (2.99) 4 (1.71) 0 (0) 4 (1.71) 1 (0.43) 0 (0) 0.839
diarrhea 7 (2.99) 14 (5.98) 5 (2.19) 8 (3.42) 5 (2.14) 1 (0.44) 6 (2.56) 12 (5.13) 1 (0.44) 0.204
drowsiness 13 (5.56) 0 (0) 0 (0) 5 (2.14) 1 (0.43) 0 (0) 2 (0.85) 0 (0) 0 (0) 0.843
eating disorder 5 (2.14) 2 (0.85) 0 (0) 0 (0) 0 (0) 0 (0) 3 (1.28) 0 (0) 0 (0) 0.494
Allergic reaction 1 (0.43) 1 (0.43) 0 (0) 1 (0.43) 1 (0.43) 0 (0) 2 (0.85) 0 (0) 0 (0) 0.651
Others 18 (7.69) 27 (11.54) 14(6.14) 15 (6.41) 22 (9.4) 8 (3.51) 22 (9.4) 32 (13.68) 6 (2.63) 0.406